Hyperthyroidism nursing: interventions, medications, and NCLEX review

LS
By Lindsay Smith, AGPCNP
Updated March 28, 2026

Hyperthyroidism is a clinical syndrome caused by excess circulating thyroid hormone, producing a hypermetabolic state that affects virtually every organ system. It affects approximately 1.3% of Americans and is more common in women by a 7:1 ratio. The most recognizable cause — Graves’ disease — is an autoimmune condition and the source of one of nursing’s most distinctive clinical findings: exophthalmos. For nursing students, hyperthyroidism represents the opposite end of the thyroid spectrum from hypothyroidism: where hypothyroidism slows everything down, hyperthyroidism speeds everything up. This reference covers the complete pathophysiology, clinical presentation by body system, diagnostic lab interpretation, priority nursing interventions, pharmacological management, and the life-threatening emergency of thyroid storm — plus six NCLEX-style questions with full rationales.

Use this page alongside the hypothyroidism nursing reference for direct comparison, the nursing lab values cheat sheet for TSH and free T4 interpretation, the atrial fibrillation nursing reference for cardiac complications of untreated hyperthyroidism, and the electrolyte imbalances reference for hypercalcemia management in hyperthyroid states.

Quick referenceKey fact
DefinitionExcess thyroid hormone production leading to hypermetabolic state
Most common cause (US)Graves' disease — diffuse toxic goiter with autoimmune TSH receptor stimulation
Second most commonToxic multinodular goiter (Plummer disease)
Hallmark signsTachycardia, heat intolerance, weight loss, tremor, diaphoresis, anxiety
Graves'-specific findingExophthalmos (proptosis), pretibial myxedema, thyroid bruit
Priority labTSH — suppressed (<0.1 mIU/L) in primary hyperthyroidism
Confirmatory labsElevated free T4 and/or free T3
Life-threatening complicationThyroid storm (thyrotoxic crisis) — mortality up to 30% with treatment
Antithyroid drugsPropylthiouracil (PTU), methimazole — block new hormone synthesis
NCLEX priority nursing concernCardiac monitoring — tachycardia, atrial fibrillation risk, wide pulse pressure

Pathophysiology of hyperthyroidism

The thyroid gland produces thyroxine (T4) and triiodothyronine (T3) under the control of the hypothalamic-pituitary-thyroid (HPT) axis. In normal physiology, the hypothalamus releases thyrotropin-releasing hormone (TRH), which stimulates the anterior pituitary to secrete thyroid-stimulating hormone (TSH). TSH then binds to receptors on thyroid follicular cells, stimulating synthesis and secretion of T4 and T3. Rising T3 and T4 levels feed back to suppress TRH and TSH — a tight negative feedback loop that keeps thyroid hormone within a narrow physiological range.

In hyperthyroidism, this feedback loop is overridden or bypassed. The mechanism depends on the underlying cause, but the result is always the same: excess free T4 and T3 circulate in the blood, driving a globally accelerated metabolic state. Because thyroid hormones increase oxygen consumption and heat production in every tissue, excess hormone accelerates cardiac rate and contractility, increases GI motility, raises basal metabolic rate (causing weight loss despite increased appetite), and amplifies the effects of catecholamines — explaining the anxiety, tremor, and cardiovascular hyperactivity seen clinically.

TSH is suppressed in primary hyperthyroidism because the pituitary senses excess hormone and reduces TSH output. This is why a suppressed TSH (typically <0.1 mIU/L) is the most sensitive screening test for hyperthyroidism and always the first lab ordered.


Causes and classification

Cause Mechanism TSH Free T4 Free T3 Key distinguishing features
Graves' disease Autoimmune — TRAb antibodies stimulate TSH receptors continuously Suppressed Elevated Elevated Diffuse goiter, exophthalmos, pretibial myxedema, positive TRAb
Toxic multinodular goiter (Plummer disease) Autonomous hormone secretion by multiple hyperactive nodules Suppressed Elevated Elevated Older adults, multinodular gland on palpation, no exophthalmos
Toxic adenoma (Plummer disease, single nodule) Single autonomously functioning nodule secretes T4/T3 independently Suppressed Elevated Elevated "Hot nodule" on RAI scan; rest of gland suppressed
Subacute (de Quervain) thyroiditis Viral inflammation releases preformed hormone from follicles Suppressed Elevated (early) Elevated (early) Tender thyroid, post-viral, self-limiting; followed by transient hypothyroid phase
Postpartum thyroiditis Autoimmune inflammation in postpartum period Suppressed (early) Elevated (early) Elevated (early) Within 1 year of delivery; painless; often followed by hypothyroid phase
Exogenous T4 excess Excessive levothyroxine dose Suppressed Elevated Variable History of levothyroxine use; no goiter; low thyroglobulin
TSH-secreting pituitary adenoma Pituitary tumor secretes TSH autonomously (central hyperthyroidism) Elevated or normal Elevated Elevated Rare; elevated or inappropriately normal TSH with elevated free T4; MRI confirms

Clinical note: The TSH-secreting pituitary adenoma is the one cause of hyperthyroidism where TSH is elevated or normal rather than suppressed. This is a classic NCLEX distractor. All other primary causes suppress TSH.


Clinical manifestations by body system

Cardiovascular

The cardiovascular system is the highest-priority system in hyperthyroidism. Thyroid hormones directly increase heart rate and myocardial contractility, and they amplify the effects of catecholamines on adrenergic receptors.

  • Tachycardia — sinus tachycardia is the most consistent cardiovascular finding; resting heart rate >100 bpm is common
  • Atrial fibrillation — develops in up to 20% of patients; risk increases with age; a new onset AFib in an older adult warrants thyroid function testing
  • Widened pulse pressure — increased systolic BP with decreased diastolic BP due to high cardiac output and peripheral vasodilation
  • Increased cardiac output — can precipitate high-output heart failure in patients with underlying cardiac disease
  • Palpitations — a common presenting complaint, especially in younger patients

Neurological and psychological

  • Tremor — fine resting tremor of the hands, most visible when arms are outstretched
  • Anxiety and emotional lability — patients are often anxious, irritable, and emotionally hyperreactive; can mimic a primary anxiety disorder
  • Insomnia — difficulty falling and staying asleep due to sympathetic hyperactivation
  • Hyperreflexia — deep tendon reflexes are brisk; the “hung-up reflex” of hypothyroidism is replaced by a quick, brisk response
  • Weakness — proximal muscle weakness is common, particularly with prolonged untreated hyperthyroidism (thyrotoxic myopathy)

Gastrointestinal

  • Weight loss — despite increased appetite (hyperphagia); patients eat more but lose weight due to elevated metabolic rate
  • Diarrhea — increased GI motility; frequent loose stools
  • Nausea — common, particularly in more severe cases

Skin and thermoregulation

  • Warm, moist skin — vasodilation increases skin perfusion; diaphoresis is nearly universal
  • Heat intolerance — patients feel too hot in environments others find comfortable
  • Fine hair — hair becomes thin and silky; hair loss possible
  • Onycholysis — separation of the nail from the nail bed, particularly the ring and little fingers (Plummer nails)
  • Pretibial myxedema — a specific finding of Graves’ disease: brawny, non-pitting thickening of the skin over the anterior tibia; despite the name, it is a feature of Graves’ hyperthyroidism

Eyes (Graves’ ophthalmopathy)

Graves’ ophthalmopathy (also called thyroid eye disease or TED) affects approximately 25–50% of patients with Graves’ disease and is caused by autoimmune inflammation of retro-orbital tissues, independent of the thyroid state. Critically, eye disease can develop before, during, or after thyroid treatment.

  • Exophthalmos (proptosis) — forward protrusion of the eyeball due to retro-orbital fat and connective tissue expansion; hallmark finding of Graves’
  • Lid lag — upper eyelid lags behind the eyeball on downward gaze (von Graefe sign)
  • Lid retraction — the upper eyelid is higher than normal, producing a wide-eyed stare
  • Periorbital edema — puffiness around the eyes
  • Chemosis — conjunctival edema
  • Diplopia — double vision from extraocular muscle involvement
  • Corneal exposure — inadequate lid closure can cause corneal drying and ulceration; a corneal emergency requiring ophthalmology consultation

Thyroid gland

  • Goiter — diffuse, smooth, symmetrical enlargement in Graves’ disease; multinodular in toxic multinodular goiter; single palpable nodule in toxic adenoma
  • Thyroid bruit — an audible bruit over the thyroid gland in Graves’ disease reflects markedly increased vascularity; a distinctive clinical finding

Diagnostic lab values

Test Normal range In hyperthyroidism Clinical significance
TSH 0.4–4.0 mIU/L <0.1 mIU/L (suppressed) Most sensitive screening test; first lab to change; single best test for primary hyperthyroidism
Free T4 0.8–1.8 ng/dL Elevated (>1.8 ng/dL) Confirmatory test; elevated in overt hyperthyroidism; may be normal in subclinical or T3-predominant disease
Free T3 2.3–4.2 pg/mL Elevated (>4.2 pg/mL) Elevated in most cases; T3 toxicosis (elevated T3 with normal T4) can occur in Graves' and toxic adenoma
TSH receptor antibodies (TRAb) Negative Positive in Graves' disease Confirms Graves' etiology; elevated in 95%+ of active Graves' disease; also useful for predicting remission
Anti-TPO antibodies Negative Positive in Graves' and Hashimoto thyroiditis Marker of autoimmune thyroid disease; less specific than TRAb for Graves'
Radioactive iodine uptake (RAIU) 10–30% at 24h Elevated in Graves' and toxic nodular goiter; low/absent in thyroiditis and exogenous T4 Distinguishes causes: Graves' = diffuse high uptake; toxic adenoma = focal hot nodule; thyroiditis = suppressed uptake
Thyroid ultrasound Homogeneous parenchyma Diffuse enlargement ± increased vascularity (Graves'); nodules in toxic multinodular goiter Structural assessment; identifies nodules; increased vascularity ("thyroid inferno") on Doppler in Graves'
CBC WBC 4,500–11,000/µL Mild anemia possible; monitor WBC closely during antithyroid drug therapy Agranulocytosis (WBC <500/µL) is a rare but life-threatening complication of PTU and methimazole

Priority nursing interventions

The cardiac system is the priority focus for hyperthyroidism nursing care. Dysrhythmias and high-output cardiac stress are the most immediately life-threatening manifestations.

1. Cardiac monitoring (highest priority)

  • Continuous cardiac monitoring for patients with known or suspected atrial fibrillation
  • Assess apical heart rate for full minute — HR >110 bpm at rest requires physician notification
  • Monitor blood pressure for widened pulse pressure (e.g., 160/60 mmHg)
  • Assess for palpitations, chest pain, dyspnea
  • Administer beta blockers (propranolol) as prescribed to reduce heart rate and control symptoms

2. Energy conservation and rest

  • Provide a quiet, low-stimulation environment — noise and activity worsen anxiety and tachycardia
  • Schedule nursing care activities to allow uninterrupted rest periods
  • Limit visitors if the patient is anxious or tachycardic
  • Assist with ADLs if muscle weakness is present (thyrotoxic myopathy)

3. Nutritional support and fluid replacement

  • High-calorie, high-protein diet: patients may need 4,000–5,000 kcal/day to offset hypermetabolic demands
  • Frequent small meals — large meals can worsen GI discomfort
  • Avoid caffeine and stimulants — they amplify sympathetic effects (palpitations, anxiety, tremor)
  • Encourage liberal fluid intake to replace insensible losses from diaphoresis
  • Weigh daily — continued weight loss despite adequate intake indicates inadequate metabolic compensation

4. Thermoregulation

  • Provide a cool environment; patients with heat intolerance are significantly uncomfortable in warm rooms
  • Cool, light bedding and clothing
  • Sponge baths with tepid water for comfort (not cold — reserve ice packs for thyroid storm)

5. Eye care for Graves’ ophthalmopathy

Graves’ ophthalmopathy requires targeted nursing interventions to protect the corneas:

  • Artificial tears (lubricating eye drops) during the day; lubricating eye ointment at night
  • Elevate the head of the bed to reduce periorbital edema
  • Instruct the patient to wear wraparound sunglasses outdoors (eye protection from UV and wind)
  • Tape eyelids closed at night if exophthalmos prevents complete lid closure — prevents corneal drying and ulceration
  • Monitor for corneal redness, pain, or visual changes — report immediately; corneal ulceration is an ophthalmological emergency

6. Safety and fall prevention

  • Fine hand tremor increases fall risk, particularly when combined with proximal muscle weakness
  • Keep side rails up; assist with ambulation
  • Remove environmental hazards

7. Patient education

  • Explain the importance of antithyroid medication compliance and regular lab monitoring
  • Teach the patient to report sore throat, fever, or mouth sores immediately — these are warning signs of agranulocytosis (antithyroid drug toxicity)
  • Educate about radioactive iodine precautions if RAI therapy is planned
  • Counsel on pregnancy considerations — methimazole is teratogenic in the first trimester; PTU preferred in first trimester

Pharmacological management

Drug / class Mechanism Use Key nursing considerations
Propylthiouracil (PTU) Blocks thyroid peroxidase (inhibits new hormone synthesis); also blocks peripheral T4→T3 conversion First-line in thyroid storm; preferred in first trimester of pregnancy; Graves' disease Monitor CBC for agranulocytosis (rare but fatal); teach patient to report sore throat, fever, mouth sores immediately — hold drug and notify provider. Hepatotoxicity risk (black box warning). Divided doses (2–3x daily). Slower onset than methimazole.
Methimazole (Tapazole) Blocks thyroid peroxidase — inhibits new T4 and T3 synthesis (does NOT block peripheral conversion) Preferred agent for non-pregnant adults and children; Graves' disease; pre-surgical preparation Same agranulocytosis risk as PTU — teach same warning signs. Teratogenic in first trimester (can cause aplasia cutis). Once-daily dosing improves compliance. Preferred over PTU except in first trimester and thyroid storm.
Propranolol (Inderal) Non-selective beta blocker — blocks adrenergic effects of excess thyroid hormone; also partially blocks T4→T3 conversion at high doses Rapid symptom control (tachycardia, tremor, anxiety, diaphoresis); thyroid storm first-line; bridge therapy while awaiting RAI or antithyroid drug effect Does NOT reduce hormone levels — symptom control only. Contraindicated in bronchospastic disease (asthma, COPD). Monitor HR and BP. Use atenolol (beta-1 selective) as alternative in reactive airway disease.
Radioactive iodine (RAI, I-131) Radioiodine is taken up by thyroid cells and destroys them through local radiation Definitive treatment for Graves' disease and toxic nodular goiter; most commonly used definitive therapy in the US Contraindicated in pregnancy and breastfeeding (absolutely). Temporary worsening of hyperthyroidism possible in first weeks. Can worsen Graves' ophthalmopathy. Radiation precautions: avoid close contact with pregnant women and children for 1 week; separate bodily fluids; use separate bathroom. Most patients develop permanent hypothyroidism and will need lifelong levothyroxine.
Saturated solution of potassium iodide (SSKI / Lugol's solution) Wolf-Chaikoff effect: high iodine load temporarily inhibits thyroid hormone synthesis and release; also reduces thyroid vascularity pre-operatively Pre-operative preparation for thyroidectomy (reduces vascularity); adjunct in thyroid storm; used after nuclear exposure to block thyroid iodine uptake Must be given AFTER antithyroid drugs — if given alone, iodine load can paradoxically worsen hyperthyroidism (provides substrate for hormone synthesis). Dilute in juice or water to reduce gastric irritation. Short-term use only.
Glucocorticoids (hydrocortisone, dexamethasone) Reduce T4→T3 peripheral conversion; have anti-inflammatory effects in Graves' ophthalmopathy; prevent relative adrenal insufficiency in thyroid storm Thyroid storm; severe Graves' ophthalmopathy; post-RAI inflammation Use IV hydrocortisone in thyroid storm — give after blocking hormone release. Monitor blood glucose (hyperglycemia is a common side effect).
Cholestyramine Bile acid sequestrant — binds thyroid hormones in the gut and reduces enterohepatic recirculation Adjunct in thyroid storm when very rapid hormone reduction is needed Separates from other medications (binds drugs in gut); less commonly used; most relevant as a test question distractor in storm management

PTU vs methimazole — key nursing comparison

Both PTU and methimazole require agranulocytosis monitoring. Teach all patients receiving either drug:

  • Report sore throat, fever, mouth sores, or unusual bruising immediately
  • If these symptoms occur, hold the drug and contact the provider — do not wait for labs
  • A CBC will be ordered; if WBC <1,000/µL (particularly neutrophils <500/µL), the drug is permanently discontinued
  • Agranulocytosis is rare (~0.3%) but potentially fatal; it is more likely in the first 3 months of therapy

First trimester pregnancy: PTU is preferred because methimazole is associated with aplasia cutis and embryopathy. After the first trimester, methimazole is preferred because PTU carries a rare but serious hepatotoxicity risk.


Thyroid storm (thyrotoxic crisis)

Thyroid storm is an acute, life-threatening exacerbation of hyperthyroidism. Mortality ranges from 10–30% even with aggressive treatment. It requires immediate recognition and simultaneous multi-drug management in an ICU setting.

Triggers

Common precipitating events include:

  • Surgery (especially thyroid surgery without adequate pre-operative preparation)
  • Trauma
  • Infection or sepsis (the most common trigger in hospitalized patients)
  • Radioactive iodine therapy (can transiently release hormone)
  • Abrupt discontinuation of antithyroid drugs
  • Iodine contrast agents in uncontrolled hyperthyroidism
  • Myocardial infarction, pulmonary embolism, stroke
  • Diabetic ketoacidosis

Clinical presentation

Thyroid storm is distinguished from severe hyperthyroidism by the presence of multi-organ system involvement:

  • Temperature >40°C (104°F) — high fever is a hallmark; hyperpyrexia can reach 41–42°C in severe cases
  • Extreme tachycardia >140 bpm — may progress to atrial fibrillation with rapid ventricular response
  • Altered mental status (AMS) — agitation, confusion, psychosis, and in severe cases, coma
  • Cardiovascular instability — hypertension in early storm; hypotension and shock in decompensated storm
  • GI symptoms — nausea, vomiting, diarrhea, abdominal pain, jaundice (hepatic dysfunction)
  • Diaphoresis — profuse, even in cooled environments

Burch-Wartofsky Point Scale (BWPS) — scoring thyroid storm

The Burch-Wartofsky Point Scale provides an objective scoring system to assess the likelihood of thyroid storm. Scores guide ICU admission and treatment decisions.

Parameter Finding Points
Temperature (°C / °F) 37.2–37.7 / 99–99.9°F 5
37.8–38.3 / 100–100.9°F 10
38.4–38.8 / 101–101.9°F 15
38.9–39.4 / 102–102.9°F 20
39.5–39.9 / 103–103.9°F 25
≥40.0 / ≥104°F 30
CNS effects Absent 0
Mild (agitation) 10
Moderate (delirium, psychosis, lethargy) 20
Severe (seizure, coma) 30
GI-hepatic dysfunction Absent 0
Moderate (diarrhea, nausea/vomiting, abdominal pain) 10
Severe (unexplained jaundice) 20
Heart rate (bpm) 99–109 5
110–119 10
120–129 15
130–139 20
≥140 25
Atrial fibrillation Absent 0
Present 10
Precipitating event identified Present 10
Congestive heart failure Absent 0
Mild (pedal edema) 5
Moderate (bibasilar rales) 10
Severe (pulmonary edema) 15

Interpretation: Score ≥45 = thyroid storm (treat); Score 25–44 = impending storm (strongly consider treatment); Score <25 = storm unlikely.

Emergency management protocol

Thyroid storm requires simultaneous, sequenced multi-drug therapy. The sequence matters — give in the correct order.

Step 1 — Airway, breathing, circulation: Secure IV access (large bore), supplemental oxygen, continuous cardiac monitoring, ICU transfer.

Step 2 — Identify and treat the precipitant: Broad-spectrum antibiotics if infection suspected, treat PE, MI, etc. — correcting the trigger is as important as treating the thyroid.

Step 3 — Block new hormone synthesis first: Administer PTU 500–1,000 mg loading dose, then 250 mg every 4 hours. PTU is preferred over methimazole in thyroid storm because it also blocks peripheral T4→T3 conversion.

Step 4 — Block hormone release (give SSKI 1 hour AFTER PTU): Administer SSKI or Lugol’s solution — give this at least 1 hour after PTU to prevent providing iodine substrate before synthesis is blocked. The Wolf-Chaikoff effect shuts down hormone release.

Step 5 — Control adrenergic symptoms: IV or oral propranolol (or esmolol by infusion) — titrate to HR <100 bpm. Controls tachycardia, tremor, and sympathetic hyperactivation. Monitor for bronchospasm.

Step 6 — Prevent adrenal insufficiency: IV hydrocortisone 100 mg every 8 hours — thyroid storm increases cortisol demand; relative adrenal insufficiency is common. Steroids also reduce peripheral T4→T3 conversion.

Step 7 — Aggressive fever management: Cooling blankets, ice packs to axillae, groin, and neck, tepid sponge baths. Use acetaminophen for antipyresis — NOT aspirin or NSAIDs. Aspirin displaces T4 from protein binding, acutely raising free T4 levels and worsening toxicity.

Step 8 — Supportive care: IV fluids (dextrose-containing solutions for caloric support), electrolyte replacement, thiamine if alcohol use is suspected, cardiac rate control for AFib.

Step 9 — Definitive treatment planning: Once stabilized, plan for thyroidectomy (most definitive in storm) or RAI after stabilization.

Critical NCLEX point: The order of PTU → then SSKI (1 hour later) is specifically tested. SSKI given before or without antithyroid drugs can worsen the storm by providing iodine for new hormone synthesis.


Hypothyroidism vs hyperthyroidism — comparison table

For NCLEX questions that test differentiating these conditions, the following table summarizes key contrasts. See the full hypothyroidism nursing reference for complete hypothyroidism coverage.

Parameter Hypothyroidism ("everything slows") Hyperthyroidism ("everything speeds")
TSH Elevated (primary hypothyroidism) Suppressed (<0.1 mIU/L)
Free T4 Decreased Elevated
Metabolic rate Decreased (hypometabolic) Increased (hypermetabolic)
Temperature tolerance Cold intolerance Heat intolerance
Weight Weight gain Weight loss despite increased appetite
Heart rate Bradycardia Tachycardia; AFib risk
Bowel habits Constipation Diarrhea
Deep tendon reflexes Delayed / "hung-up" (slow relaxation phase) Hyperreflexic (brisk)
Skin Dry, cool, coarse; non-pitting edema (myxedema) Warm, moist, diaphoretic; smooth, fine texture
Mood / cognition Depression, cognitive slowing, memory impairment Anxiety, emotional lability, insomnia, tremor
Hair / nails Coarse, brittle hair; hair loss; brittle nails Fine, thin hair; onycholysis (nail separation)
Life-threatening complication Myxedema coma Thyroid storm
Emergency management priority IV levothyroxine + IV hydrocortisone (before T4); passive rewarming only PTU first → then SSKI (1h later) → propranolol → hydrocortisone; active cooling; NO aspirin
Primary medication Levothyroxine (T4 replacement) PTU or methimazole (antithyroid); propranolol (symptom control)

NCLEX-style practice questions

Question 1 — Priority assessment

A nurse is caring for a 32-year-old woman newly diagnosed with Graves’ disease. On assessment, the nurse notes a resting heart rate of 118 bpm, blood pressure of 158/62 mmHg, fine hand tremor, and 12 lb unintentional weight loss over 3 months. Which finding should the nurse prioritize?

A. Fine hand tremor B. Weight loss of 12 lb C. Heart rate of 118 bpm D. Blood pressure of 158/62 mmHg

Correct answer: C — Heart rate of 118 bpm

Rationale: Using the ABCs and Maslow’s hierarchy, cardiovascular status is the highest priority in hyperthyroidism. A persistent resting tachycardia of 118 bpm represents a cardiovascular threat — hyperthyroidism-driven tachycardia can progress to atrial fibrillation, high-output heart failure, and cardiovascular decompensation. This patient requires cardiac monitoring, beta blocker administration as prescribed, and provider notification. The weight loss (B) is metabolic and concerning but not an acute cardiovascular threat. The tremor (A) requires safety measures but is not life-threatening. The blood pressure (D) with a wide pulse pressure (158/62 mmHg) is consistent with hyperthyroidism and warrants monitoring, but the tachycardia is the more immediately actionable cardiac priority.


Question 2 — Medication monitoring

A patient started methimazole 2 weeks ago for Graves’ disease. She calls the clinic reporting a sore throat and fever of 38.4°C (101.1°F). What is the nurse’s priority action?

A. Reassure the patient this is a common side effect and continue the medication B. Instruct the patient to take acetaminophen for the fever and recheck in 24 hours C. Instruct the patient to hold the methimazole immediately and go to the emergency department D. Schedule a routine lab check at next week’s appointment

Correct answer: C — Hold the methimazole and go to the emergency department

Rationale: Sore throat and fever in a patient taking antithyroid drugs (PTU or methimazole) is a warning sign of agranulocytosis — a life-threatening drop in neutrophil count that leaves the patient unable to fight infection. The nurse must instruct the patient to stop the medication immediately and seek emergency evaluation for urgent CBC. Agranulocytosis most commonly occurs in the first 3 months of therapy. Option A is dangerous — these symptoms should never be dismissed. Option B delays necessary evaluation. Option D is far too slow — this is a potential medical emergency requiring same-day CBC. The medication must be permanently discontinued if agranulocytosis is confirmed.


Question 3 — SATA: Graves’ disease manifestations

A nurse is assessing a patient with a confirmed diagnosis of Graves’ disease. Which of the following findings does the nurse anticipate? Select all that apply.

A. Exophthalmos B. Bradycardia C. Weight loss with increased appetite D. Heat intolerance E. Diaphoresis F. Constipation G. Fine hand tremor

Correct answers: A, C, D, E, G

Rationale:

  • A — Exophthalmos: CORRECT. Forward protrusion of the eyeballs is the hallmark ocular finding of Graves’ disease, caused by autoimmune retro-orbital inflammation.
  • B — Bradycardia: INCORRECT. Hyperthyroidism causes tachycardia (increased heart rate), not bradycardia. Bradycardia is a finding of hypothyroidism.
  • C — Weight loss with increased appetite: CORRECT. The hypermetabolic state consumes calories faster than even increased food intake can replace, causing weight loss despite hyperphagia.
  • D — Heat intolerance: CORRECT. Elevated metabolic rate increases thermogenesis; patients feel uncomfortably hot.
  • E — Diaphoresis: CORRECT. Increased heat production causes profuse sweating.
  • F — Constipation: INCORRECT. Hyperthyroidism increases GI motility, causing diarrhea. Constipation is a symptom of hypothyroidism.
  • G — Fine hand tremor: CORRECT. Sympathetic nervous system stimulation by excess thyroid hormone causes a characteristic fine resting tremor.

Question 4 — Thyroid storm priority intervention

A patient with uncontrolled hyperthyroidism is admitted with a temperature of 40.2°C (104.4°F), heart rate of 148 bpm, agitation, and altered mental status. Thyroid storm is suspected. Which intervention is the nurse’s highest priority after securing IV access and initiating continuous cardiac monitoring?

A. Apply cooling blankets and administer IV acetaminophen B. Administer aspirin 650 mg for fever reduction C. Prepare to administer PTU per the established protocol D. Administer SSKI (saturated solution of potassium iodide) immediately

Correct answer: C — Administer PTU

Rationale: In thyroid storm management, the sequence of drug administration matters. PTU must be given first to block new thyroid hormone synthesis before iodine (SSKI) is administered. PTU works within minutes to hours to inhibit thyroid peroxidase and block peripheral T4→T3 conversion. Once PTU is on board, SSKI can be given (at least 1 hour later) to block hormone release via the Wolf-Chaikoff effect. Option D (SSKI first) is dangerous — administering iodine before blocking synthesis provides substrate for new hormone production and can worsen the storm. Option B (aspirin) is contraindicated — aspirin displaces T4 from thyroid-binding globulin, acutely raising free T4 and worsening toxicity. Option A (cooling) is important supportive care and should proceed simultaneously, but the priority pharmacological intervention that addresses the root cause is PTU.


Question 5 — Radioactive iodine precautions

A patient with Graves’ disease received oral radioactive iodine (I-131) therapy 2 days ago. The nurse is reviewing discharge instructions. Which instruction is most important to include?

A. “You should expect to see improvement in your symptoms within 48 hours.” B. “Avoid close contact with pregnant women and young children for at least 7 days.” C. “You may share bathroom facilities with family members without restriction.” D. “Pregnancy is safe to pursue 4 weeks after treatment.”

Correct answer: B — Avoid close contact with pregnant women and young children for at least 7 days

Rationale: I-131 emits beta and gamma radiation that is present in body fluids (saliva, urine, sweat) and can cause internal radiation exposure to others. Pregnant women and young children are most vulnerable to thyroid radiation damage. Standard precautions include: avoid close contact (<3 feet) for 7 days; use a separate bathroom when possible; avoid sharing utensils; do not sleep in the same bed with a partner or children. Option A is incorrect — RAI takes 3–6 weeks to produce clinical improvement; symptoms may temporarily worsen in the first 1–2 weeks as dying thyroid cells release stored hormone. Option C is incorrect — body fluid precautions apply; a separate bathroom is preferred. Option D is incorrect — pregnancy should be avoided for 6–12 months after I-131 therapy (not 4 weeks) to ensure thyroid levels are stable and levothyroxine replacement is optimized; RAI is absolutely contraindicated during pregnancy.


Question 6 — Priority nursing diagnosis

A nurse is developing a plan of care for a patient with newly diagnosed hyperthyroidism who is experiencing a resting heart rate of 112 bpm, unintentional weight loss of 15 lb over 6 weeks despite eating more than usual, fine hand tremor, and exophthalmos. Which priority nursing diagnosis should guide the plan of care?

A. Imbalanced nutrition: less than body requirements related to hypermetabolic state B. Disturbed sensory perception: visual related to exophthalmos C. Decreased cardiac output related to tachycardia and dysrhythmia risk D. Risk for injury related to tremor and muscle weakness

Correct answer: C — Decreased cardiac output related to tachycardia and dysrhythmia risk

Rationale: Using the ABCs framework, cardiovascular integrity takes priority. A resting heart rate of 112 bpm in a patient with untreated hyperthyroidism represents a real and immediate risk of progression to atrial fibrillation, which affects up to 20% of patients and can lead to stroke, hemodynamic instability, and heart failure. Decreased cardiac output is the priority nursing diagnosis because cardiovascular compromise is immediately life-threatening. Option A (imbalanced nutrition) is a valid and important nursing concern — a 15 lb weight loss over 6 weeks is clinically significant — but nutritional deficits, while urgent, are not immediately life-threatening in the way that cardiovascular decompensation is. Options B and D are real concerns requiring nursing interventions (corneal protection, fall prevention) but rank below cardiac safety in priority.


Reviewed by Lindsay Smith, AGPCNP. For complete hypothyroidism coverage and the opposite end of the thyroid spectrum, see the hypothyroidism nursing reference. For cardiac rhythm interpretation in AFib complicating hyperthyroidism, see the atrial fibrillation nursing reference. For complete lab value interpretation, see the nursing lab values cheat sheet.